Shelly Zhong

BTK small molecule inhibitors induce a distinct pancreatic toxicity in rats

Adam R. Johnson, Li-chuan, M. Hedehus, 2016 .

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma

S. Wingert, A. M. Ovacik, D. E. de Almeida Nagata, 2022, Leukemia.

Nonclinical Pharmacokinetics, Pharmacodynamics, and Translational Model of RO7297089, A Novel Anti-BCMA/CD16A Bispecific Tetravalent Antibody for the Treatment of Multiple Myeloma

Meric A. Ovacik, A. Kamath, A. Adedeji, 2022, The AAPS Journal.

Bruton’s Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats

Adam R. Johnson, M. Hedehus, R. Carano, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Nonclinical Pharmacokinetics, Pharmacodynamics, and Translational Model of RO7297089, A Novel Anti-BCMA/CD16A Bispecific Tetravalent Antibody for the Treatment of Multiple Myeloma

Meric A. Ovacik, A. Kamath, A. Adedeji, 2022, The AAPS Journal.

Nonclinical safety assessment of a human interleukin‐22FC IG fusion protein demonstrates in vitro to in vivo and cross‐species translatability

D. Danilenko, W. Ouyang, B. Harder, 2018, Pharmacology research & perspectives.

Balancing Blood Sample Volume with 3Rs: Implementation and Best Practices for Small Molecule Toxicokinetic Assessments in Rats.

Brian Dean, Jacqueline Tarrant, B. Liederer, 2016, ILAR journal.

Nonclinical toxicology development of a novel antibody antibiotic conjugate for treating invasive Staphylococcus Aureus infections

A. Kamath, W. Halpern, P. Katavolos, 2021, Toxicology and Applied Pharmacology.